Literature DB >> 7446668

Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

Y Tano, D Chandler, R Machemer.   

Abstract

We studied the inhibitory effect of triamcinolone acetonide on experimental intraocular proliferation. Autotransplantation of fibroblasts from rabbit rump skin into the vitreous cavity resulted in intravitreal strand formation and traction retinal detachment in 36 of 43 eyes (84%) over a period of three months. A single intravitreal injection of 1 mg of triamcinolone acetonide inhibited fibroblast growth and significantly reduced the number of retinal detachments in 15 of 44 eyes (34%). Retinal neovascularization caused by fibrous strands coming into contact with vacularized retina was also reduced by triamcinolone acetonide (31 of 43 control eyes [72%] vs eight of 44 treated eyes [18%]). Intravitreal corticosteroid therapy may be an important adjunct to the therapy of perforating injuries and massive periretinal proliferation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7446668     DOI: 10.1016/s0002-9394(14)75196-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  67 in total

1.  Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.

Authors:  Paul B Greenberg; Adam Martidis; Adam H Rogers; Jay S Duker; Elias Reichel
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

4.  Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  E Rechtman; R P Danis; L M Pratt; A Harris
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

5.  Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

6.  Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications.

Authors:  G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  Treatment of recurrent retinal angiomatous proliferation with intravitreal triamcinolone acetonide followed by photodynamic therapy with verteporfin: A retrospective case series.

Authors:  Nicola Cardascia; Claudio Furino; Andrea Ferrara; Francesco Boscia; Giovanni Alessio
Journal:  Curr Ther Res Clin Exp       Date:  2009-06

8.  Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial.

Authors:  Fritz Koerner; Ursula Koerner-Stiefbold; Justus G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-21       Impact factor: 3.117

9.  Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study.

Authors:  S Binder; M Bonnet; M Velikay; J P Gerard; U Stolba; A Wedrich; H Hohenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

10.  Experimental study on drug therapy of "traction retinal detachment" after posterior penetrating eye injury in the rabbit.

Authors:  W Behrens-Baumann; M Vogel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.